Announcement of management change

Mariko Tosu has resigned Chair and Board member.

We inform that Mariko Tosu has resigned Chair and Board member.
Under the newly appointed president, Philip Davy, we will continue to strive to realize our vision of becoming a leading company in drug delivery to the brain for central nervous system diseases as quickly as possible. We will unite and devote to the development of our business, so we ask for your support continuously.